J. Allen et al., COMPARISON OF LOWER-LIMB ARTERIAL ASSESSMENTS USING COLOR-DUPLEX ULTRASOUND AND ANKLE BRACHIAL PRESSURE INDEX MEASUREMENTS, Angiology, 47(3), 1996, pp. 225-232
The strength of agreement between two noninvasive methods of assessing
lower limb arterial disease and their relationship to patient symptom
s following exercise have been investigated. Color-duplex ultrasound (
CDU) and ankle/brachial pressure index (ABPI) (before and after exerci
se) measurements were obtained from 200 consecutive patients referred
to a vascular investigations laboratory. From these patients, 290 limb
s were available for study, comprising limbs without previous vascular
surgery, from patients without diabetes and who could attempt a walki
ng exercise test. The overall level of agreement between CDU and resti
ng ABPI measurements was 83% (Kappa 0.66). The ABPI technique identifi
ed the more serious disease; a resting ABPI of less than 0.6 gave 100%
agreement with CDU. With higher resting ABPIs the level of agreement
became poorer: 83% (0.6 less than or equal to ABPI < 0.9) and 76% (nor
mal ABPI greater than or equal to 0.9). The addition of postexercise A
BPI measurements in determining significant arterial disease increased
the strength of relationship between the two techniques by only 2% (8
5%, Kappa 0.69). The exercise test was generally limited by the most s
ymptomatic limb in each patient, and the agreement between CDU and pos
texercise ABPI measurements in these limbs was higher at 93% (Kappa 0.
81). In comparison, agreement for the least symptomatic group of limbs
was found to be poor (69%, Kappa 0.37). Compared with symptoms after
exercise, overall agreements with CDU and ABPI were both 67% (Kappa 0.
27). The agreement was better (91%) when the resting ABPI was less tha
n 0.6. The ABPI is biased toward the detection of more severe disease
and is more consistent with CDU when the most symptomatic limbs are co
mpared. The relationship between either test and symptoms after exerci
se is strong only for limbs with major disease.